Insider Trading History of Prado Nanci

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Prado Nanci since 2007. The trader's CIK number is 1374243. At the time of the last reporting, Prado Nanci was the General Counsel of Maidenform Brands, Inc.. (stock ticker symbol MFB). Also see all insider trading activities at Maidenform Brands, Inc..

Note that in the past Prado Nanci also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Omrix Biopharmaceuticals, Inc. (OMRI) by Prado Nanci

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 OMRI 0 $0 9,000 $337,590 9,000 $146,969

Yearly summary of insider trading at Maidenform Brands, Inc. (MFB) by Prado Nanci

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 MFB 0 $0 1,643 $36,082 3,592 $45,797


Insider trading activities at 2 companies by Prado Nanci:

1. Omrix Biopharmaceuticals, Inc. (OMRI)

2. Maidenform Brands, Inc. (MFB)

Table 1. Insider trading of Omrix Biopharmaceuticals, Inc. (OMRI) by Prado Nanci

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-11-08 OMRI Sale 9,000 37.51 337,590
2007-11-08 OMRI Option Ex 9,000 16.33 146,969

Table 2. Insider trading of Maidenform Brands, Inc. (MFB) by Prado Nanci

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-05-15 MFB Sale 283 21.03 5,951
2012-05-11 MFB Sale 800 21.82 17,456
2012-05-11 MFB Option Ex 1,197 12.75 15,261
2012-03-14 MFB Option Ex 2,395 12.75 30,536
2012-03-14 MFB Sale 560 22.63 12,675

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Prado Nanci (General Counsel of Maidenform Brands, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.